Fig. 1
From: Assessment of IMPT versus VMAT plans using different uncertainty scenarios for prostate cancer
Patient-specific comparison of VMATorig to IMPTRO3 and IMPTRO5 nominal cohorts. In all panels, filled circles represent comparisons between patients VMATorig and IMPTRO3 dose-distributions. Hollow squares represent comparisons between VMATorig and IMPTRO5 dose-distributions. All marks below the diagonal identity line indicate that IMPT plans were preferable to VMAT for the specific dose metric in each panel. Left column panels displays CTV statistics. From top to bottom, Dmax, CI, and HI metrics are shown in this column. Middle column displays anorectum dose metrics and right column displays bladder dose metrics. For both columns, from top to bottom, V4000cGy, V6500cGy, and V8000cGy metrics are shown for each organ.